Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: drug profile and expert opinion on the prevention and management of adverse events.
Saved in:
| Title: | Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: drug profile and expert opinion on the prevention and management of adverse events. |
|---|---|
| Authors: | Derenzini, Enrico1,2 (AUTHOR) enrico.derenzini@ieo.it, Gibb, Adam3 (AUTHOR), Kwiatek, Michał4 (AUTHOR), Strati, Paolo5 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Nov2025, Vol. 66 Issue 11, p1990-2002. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428194.2025.2520440 |
